Free Trial

Inspire Medical Systems Q4 2024 Earnings Report

Inspire Medical Systems logo
$176.87 -1.52 (-0.85%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Inspire Medical Systems EPS Results

Actual EPS
$1.15
Consensus EPS
$0.74
Beat/Miss
Beat by +$0.41
One Year Ago EPS
N/A

Inspire Medical Systems Revenue Results

Actual Revenue
N/A
Expected Revenue
$239.76 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Inspire Medical Systems Announcement Details

Quarter
Q4 2024
Time
After Market Closes

Inspire Medical Systems Earnings Headlines

This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Leerink Partnrs Has Bullish Forecast for INSP Q1 Earnings
FY2028 Earnings Estimate for INSP Issued By Leerink Partnrs
See More Inspire Medical Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inspire Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inspire Medical Systems and other key companies, straight to your email.

About Inspire Medical Systems

Inspire Medical Systems (NYSE:INSP), a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

View Inspire Medical Systems Profile

More Earnings Resources from MarketBeat